Namenda XR Coupon - Namenda XR 14mg capsule

Memantine ER

MEMANTINE is used to treat dementia caused by Alzheimer's disease. The lowest GoodRx price for the most common version of memantine ER is around $118.10, 71% off the average retail price of $413.72. Compare NMDA receptor antagonists.
Namenda XR Coupon - Namenda XR 14mg capsule

Namenda XR Latest News

Get the latest updates on this drug from the GoodRx medical team

48 Prescription Medications To Be Dropped by Insurance in 2019

Benita Lee - August 09, 2018

As drug makers are facing increasing scrutiny over high drug prices, pharmacy benefit manager (PBM) Express Scripts announces that they will be excluding 48 new drugs from insurance coverage in 2019. If you have insurance, it’s time to pay attention.

Every year, PBMs like Express Scripts evaluate the clinical value and financial cost of prescription medications and create a list of drugs covered by insurance, known as formularies. See More

10 Best Ways to Prevent Dementia

Dr. Sharon Orrange - March 22, 2016

The most feared medical condition in folks over 55? Dementia—specifically Alzheimer’s dementia—according to multiple surveys. Cancer is a distant second.

The majority of dementia cases are Alzheimer’s dementia (AD), yet there is currently no easy way to screen for AD. Neuropsychological testing is still the gold standard (this is testing that takes a few hours with a neuropsychologist). Genetic tests are available but only for the rarer early onset form (a small percentage of dementia cases). See More

Can I Be Tested for Alzheimer Disease?

Dr. Sharon Orrange - September 29, 2015

Studies show that Alzheimer Disease is feared more than any other medical condition in people over 55, even cancer. It’s normal to be concerned if you find your memory is not as good as it used to be as you get older.
You may wonder: is this normal memory loss or do you have Alzheimer Disease (AD)? Are there any tests that can help you find out? There are a few ways to narrow it down.
Neuropsychological testing. See More

What’s New in Alzheimer Disease Treatment?

Dr. Sharon Orrange - July 28, 2015

There are 8 million new cases of Alzheimer disease (AD) each year—and while new headlines appear every week about potential cures, it may discourage you to know that many recent AD trials have been unsuccessful, though not for a lack of trying. In fact, there have been no new medication approvals for this currently untreatable disease in over ten years.

What about drugs already on the market? Current medications like donepezil (Aricept) and memantine (Namenda) have some benefits for symptoms, but don’t slow progression or prevent the disease. See More

Generic Namenda Is (Finally) in Pharmacies

Elizabeth Davis - July 22, 2015

After a long, complicated path, Alzheimers prescription Namenda finally has a generic in the form of memantine. Memantine is now in pharmacies—though for a while it looked like there might never be a generic Namenda at all.

First came the announcement in 2014 that Forest Pharmaceuticals was discontinuing Namenda and replacing it with Namenda XR.

Why the discontinuation? There were no safety or effectiveness concerns with the regular-release Namenda—but the patent expired in mid-2015, making a generic possible. See More

New Alzheimer’s Med Namzaric Approved

Roni Shye - January 13, 2015

Namzaric (memantine/donepezil) is a new combination drug approved on December 24, 2014 for the treatment of moderate to severe dementia of the Alzheimer type (Alzheimer’s disease) in patients already taking Namenda XR (memantine) and Aricept (donepezil).

What is Alzheimer’s disease?

Alzheimer’s disease involves a decline in mental ability that is severe enough to affect daily activities. It is a progressive disease that follows three stages: mild, moderate, and severe. See More

Reminder! Namenda Tablets Have Been Discontinued

Roni Shye - August 15, 2014

Effective Friday, August 15, 2014, Namenda (memantine) 5 mg and 10 mg tablets have been discontinued. According to the manufacturer, Forest Laboratories, the discontinuation is not for safety reasons, but because the company is going to be focusing on their once-daily Namenda XR (memantine) capsules.

For more information regarding the discontinuation of Namenda tablets click here.

What strengths and forms of Namenda XR are still available?
Namenda XR is available as a once-daily capsule in 7 mg, 14 mg, 21 mg, and 28 mg dosages. See More

Does Namenda Work for Migraine Headaches?

Dr. Sharon Orrange - June 19, 2014

Quite a bit of buzz around Namenda (memantine) for prevention of migraine headache. Namenda is a medication used to treat dementia, so why in the world would it work for migraine prevention?

For people who suffer with 3 – 4 headaches a month and have been refractory or can’t tolerate other therapies, Namenda may be an option.

Listen up.

No More Namenda Means No Generic Next Year

Dr. Sharon Orrange - May 14, 2014

Last month, I wrote that Namenda was being discontinued by the manufacturer (see the post here), to be replaced with the longer-acting Namenda XR. Forest Laboratories announced its plan to discontinue the sale of Namenda 5mg and 10mg tablets but not because of any safety or efficacy issues, just because they have a longer acting form they want you to use instead.

Now, why is this a bummer for you? While it looks like Namenda XR is the same price (even a little cheaper) than Namenda, immediate release Namenda was going to lose its patent next year. See More

Alzheimer’s Drug Namenda to Be Discontinued, Replaced With Namenda XR

Dr. Sharon Orrange - April 11, 2014

No more Namenda? Not really, but the shorter-acting form is going away. Forest Laboratories has announced its plan to discontinue the sale of Namenda 5 mg and 10 mg tablets—but not because of any safety or efficacy issues, just because they have a longer-acting form available.

Namenda is an NMDA receptor antagonist approved for the treatment of moderate-to-severe Alzheimer’s dementia. Both the liquid form, Namenda oral solution, and the extended-release capsules, Namenda XR, will continue to be available. See More

GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.
In all states except Tennessee, GoodRx is considered a marketer of prescription discount cards, and is not required to register as a discount card provider. In Tennessee, GoodRx is registered as a Prescription Drug Discount Plan Operator.
Safe Pharmacy